Correlation Between Myriad Genetics and Medpace Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Myriad Genetics and Medpace Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Myriad Genetics and Medpace Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Myriad Genetics and Medpace Holdings, you can compare the effects of market volatilities on Myriad Genetics and Medpace Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Myriad Genetics with a short position of Medpace Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Myriad Genetics and Medpace Holdings.

Diversification Opportunities for Myriad Genetics and Medpace Holdings

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Myriad and Medpace is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Myriad Genetics and Medpace Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medpace Holdings and Myriad Genetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Myriad Genetics are associated (or correlated) with Medpace Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medpace Holdings has no effect on the direction of Myriad Genetics i.e., Myriad Genetics and Medpace Holdings go up and down completely randomly.

Pair Corralation between Myriad Genetics and Medpace Holdings

Given the investment horizon of 90 days Myriad Genetics is expected to generate 125.0 times less return on investment than Medpace Holdings. In addition to that, Myriad Genetics is 1.21 times more volatile than Medpace Holdings. It trades about 0.0 of its total potential returns per unit of risk. Medpace Holdings is currently generating about 0.04 per unit of volatility. If you would invest  28,145  in Medpace Holdings on September 2, 2024 and sell it today you would earn a total of  5,918  from holding Medpace Holdings or generate 21.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Myriad Genetics  vs.  Medpace Holdings

 Performance 
       Timeline  
Myriad Genetics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Myriad Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Medpace Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medpace Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Medpace Holdings is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Myriad Genetics and Medpace Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Myriad Genetics and Medpace Holdings

The main advantage of trading using opposite Myriad Genetics and Medpace Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Myriad Genetics position performs unexpectedly, Medpace Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will offset losses from the drop in Medpace Holdings' long position.
The idea behind Myriad Genetics and Medpace Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Transaction History
View history of all your transactions and understand their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk